Antidepressant effects of ketamine in depressed patients

  title={Antidepressant effects of ketamine in depressed patients},
  author={Robert M. Berman and Angela Cappiello and Amit Anand and Dan A. Oren and George R. Heninger and Dennis S. Charney and John H. Krystal},
  journal={Biological Psychiatry},

Figures from this paper

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Robust and rapid antidepressant effects resulted from a single intravenous dose of an N-methyl-D-aspartate antagonist; onset occurred within 2 hours postinfusion and continued to remain significant for 1 week.
Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
A substantial relationship between ketamine's antidepressant and psychotomimetic effects was found, and this relationship could be mediated by the initial steps of ketamine’s action, trough NMDA receptors, shared by both ketamines' clinical effects.
The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
It is hypothesized that ketamine directly mediates this throughput, whereas monoaminergic antidepressants work indirectly and gradually; this may explain, in part, the lag of onset of several weeks to months that is observed with traditional antidepressants.
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Rapid Antidepressant Effect of Ketamine in the Electroconvulsive Therapy Setting
Ketamine, at a dose of 0.5 mg/kg, given just before ECT, did not enhance the antidepressant effect of ECT and the results suggest that the coadministration of ketamine with a barbiturate anesthetic and ECT may attenuate the immediate antidepressant effects of the N-methyl-D-aspartate antagonist.
Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A preliminary PET study
Results indicate that treatment-resistant MDD subjects showed decreased metabolism in the right habenula and the extended medial and orbital prefrontal networks in association with rapid antidepressant response to ketamine, and metabolism increased in sensory association cortices.
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
This is the first report to the authors' knowledge to demonstrate the dose-related efficacy of R/S-ketamine for treatment-resistant depression and the first to characterize ketamine effects in a genotyped Chinese population in which most patients possessed at least one copy of the lower functioning Met allele of the BDNF gene.


Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.
It is proposed that adaptive changes in NMDA receptors may be the final common pathway for antidepressant action.
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
These data indicate that N-methyl-D-aspartate antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.
Loading dose imipramine--new approach to pharmacotherapy of melancholic depression.
Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial.
Pulse clomipramine (200 mg i.v.) is associated with dramatic reduction in depressive symptoms at day 6 after infusion, which is significantly different from the effect of placebo.
Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression.
Acute antidepressant effect following pulse loading with intravenous and oral clomipramine.
Pronounced early improvements in severe depressive symptoms may be achieved via loading dose regimens with clomipramine in the absence of continuous treatment, as was the amelioration in the Raskin Severity for Depression Scale and the Beck Depression Inventory scores.
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions.
Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice